Prostatis Group’s Panagram BBB-B CLO ETF CLOZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$330K Sell
12,484
-2
-0% -$52 0.08% 137
2026
Q1
$320K Buy
12,486
+335
+3% +$8.78K 0.08% 137
2025
Q4
$322K Buy
+12,151
New +$323K 0.08% 131

Other funds holding CLOZ

Prostatis Group's CLOZ Position: Q2 2026 in Review

Prostatis Group reduced its Panagram BBB-B CLO ETF (CLOZ) stake by 0.02% in Q2 2026, selling an estimated $52 and leaving 12,484 shares worth $330K. The position accounts for 0.08% of the portfolio, ranked #137.

Prostatis Group first reported a position in CLOZ in Q4 2025 and has held it in 3 quarters since. 93 funds tracked by Wall St. Rank hold CLOZ as of Q2 2026.

  • Prostatis Group held 12,484 shares of Panagram BBB-B CLO ETF worth $330K as of Q2 2026.
  • Prostatis Group sold 2 Panagram BBB-B CLO ETF shares in Q2 2026, an estimated $52.
  • Panagram BBB-B CLO ETF made up 0.08% of Prostatis Group's portfolio in Q2 2026, its #137 holding.
  • Prostatis Group first reported a position in Panagram BBB-B CLO ETF in Q4 2025 and has held it in 3 quarters since.
  • 93 funds tracked by Wall St. Rank held Panagram BBB-B CLO ETF as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.